Ardelyx, Inc.
NASDAQ:ARDX
Overview | Financials
Company Name | Ardelyx, Inc. |
Symbol | ARDX |
Currency | USD |
Price | 4.64 |
Market Cap | 1,099,002,560 |
Dividend Yield | 0% |
52-week-range | 4.32 - 10.13 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Michael G. Raab |
Website | https://www.ardelyx.com |
An error occurred while fetching data.
About Ardelyx, Inc.
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD